menu
    • menu

    Company profile for Intensity Therapeutics

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Intensity Therapeutics is a clinical stage, biotechnology company whose mission is to greatly extend the lives of cancer patients. Our lead product, INT230-6, is currently in human clinical testing to treat refractory solid tumor cancers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Intensity TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    61 Wilton Road, 3rd Floor, Westport, CT 06880
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://intensitytherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Intensity Therapeutics To Present 2 Posters At 2025 San Antonio
    Intensity Therapeutics To Present 2 Posters At 2025 San Antonio

    11 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/intensity-therapeutics-inc-to-present-two-posters-at-the-2025-san-antonio-breast-cancer-symposium-302638554.html

    PR NEWSWIRE
    11 Dec 2025
    Share Share
    Intensity Therapeutics Secures Nasdaq Bid Price Extension
    Intensity Therapeutics Secures Nasdaq Bid Price Extension

    05 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/intensity-therapeutics-granted-180-day-extension-to-regain-compliance-with-nasdaqs-minimum-bid-price-requirement-302633691.html

    PR NEWSWIRE
    05 Dec 2025
    Share Share
    Intensity Therapeutics Announces Two Presentations at 2025 SABCS
    Intensity Therapeutics Announces Two Presentations at 2025 SABCS

    04 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/intensity-therapeutics-announces-two-presentations-at-the-upcoming-2025-san-antonio-breast-cancer-symposium-302632674.html

    PR NEWSWIRE
    04 Dec 2025
    Share Share
    Intensity Therapeutics Reveals Q3 2025 Financials & Corporate
    Intensity Therapeutics Reveals Q3 2025 Financials & Corporate

    06 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/intensity-therapeutics-reports-third-quarter-2025-financial-results-and-provides-corporate-update-302607692.html

    PR NEWSWIRE
    06 Nov 2025
    Share Share
    Intensity Therapeutics Prices $4M Stock Offering
    Intensity Therapeutics Prices $4M Stock Offering

    31 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/intensity-therapeutics-inc-announces-pricing-of-4-million-registered-direct-offering-of-common-stock-302600767.html

    PR NEWSWIRE
    31 Oct 2025
    Share Share
    Intensity Therapeutics Reveals Clinical Results of INT230-6
    Intensity Therapeutics Reveals Clinical Results of INT230-6

    30 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/intensity-therapeutics-inc-announces-publication-of-clinical-results-of-int230-6-for-the-treatment-of-metastatic-or-refractory-cancers-in-ebiomedicine-a-lancet-discovery-science-journal-302599519.html

    PR NEWSWIRE
    30 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search